OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Plasma filtration for the controlled removal of liposomal therapeutics – From the apheretic site of view
M. Bláha, Jiřina Martı́nková, M. Lánská, et al.
Atherosclerosis Supplements (2017) Vol. 30, pp. 286-293
Closed Access | Times Cited: 6
M. Bláha, Jiřina Martı́nková, M. Lánská, et al.
Atherosclerosis Supplements (2017) Vol. 30, pp. 286-293
Closed Access | Times Cited: 6
Showing 6 citing articles:
Coagulation in familial hypercholesterolemic patients: effect of current hypolipidemic treatment and anticoagulants
Jaka Fadraersada, Raúl Alva-Gallegos, Pavel Skořepa, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Jaka Fadraersada, Raúl Alva-Gallegos, Pavel Skořepa, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Pegylated liposomal doxorubicin-related palmar-plantar erythrodysesthesia: a literature review of pharmaceutical and clinical aspects
Yao Zhu, Fenfen Wang, Yunchun Zhao, et al.
European Journal of Hospital Pharmacy (2020) Vol. 28, Iss. 3, pp. 124-128
Open Access | Times Cited: 10
Yao Zhu, Fenfen Wang, Yunchun Zhao, et al.
European Journal of Hospital Pharmacy (2020) Vol. 28, Iss. 3, pp. 124-128
Open Access | Times Cited: 10
Extracorporeal Removal of Thermosensitive Liposomal Doxorubicin from Systemic Circulation after Tumor Delivery to Reduce Toxicities
Anjan Motamarry, Amber Wolfe, Krishna Kumar Ramajayam, et al.
Cancers (2022) Vol. 14, Iss. 5, pp. 1322-1322
Open Access | Times Cited: 4
Anjan Motamarry, Amber Wolfe, Krishna Kumar Ramajayam, et al.
Cancers (2022) Vol. 14, Iss. 5, pp. 1322-1322
Open Access | Times Cited: 4
Plasmafiltration as an effective method in the removal of circulating pegylated liposomal doxorubicin (PLD) and the reduction of mucocutaneous toxicity during the treatment of advanced platinum-resistant ovarian cancer
Ondřej Kubeček, Jiřina Martı́nková, Jaroslav Chládek, et al.
Cancer Chemotherapy and Pharmacology (2019) Vol. 85, Iss. 2, pp. 353-365
Closed Access | Times Cited: 4
Ondřej Kubeček, Jiřina Martı́nková, Jaroslav Chládek, et al.
Cancer Chemotherapy and Pharmacology (2019) Vol. 85, Iss. 2, pp. 353-365
Closed Access | Times Cited: 4
Therapeutic Apheresis, Circulating PLD, and Mucocutaneous Toxicity: Our Clinical Experience through Four Years
Stanislav Filip, Ondřej Kubeček, Jiří Špaček, et al.
Pharmaceutics (2020) Vol. 12, Iss. 10, pp. 940-940
Open Access | Times Cited: 3
Stanislav Filip, Ondřej Kubeček, Jiří Špaček, et al.
Pharmaceutics (2020) Vol. 12, Iss. 10, pp. 940-940
Open Access | Times Cited: 3
The Content of TBA Products in the Blood Serum of Rats for Evaluation of the Antioxidant Defense of the Body by the Liposomal Drug Lioliv after the Application of Оxaliplatin
E. G. Barder, Alexander S. Dudnichenko
Ukraïnsʹkij žurnal medicini bìologìï ta sportu (2018) Vol. 3, Iss. 2, pp. 12-15
Open Access
E. G. Barder, Alexander S. Dudnichenko
Ukraïnsʹkij žurnal medicini bìologìï ta sportu (2018) Vol. 3, Iss. 2, pp. 12-15
Open Access
